When you get a COVID-19 shot, a big hope is that it will keep you from getting so sick you need urgent medical care. A recent study tried to measure exactly that, checking if the updated bivalent vaccines prevented emergency room visits, urgent care trips, and hospitalizations in healthy adults across nine states. The research, which looked at real-world data, has not yet reported its findings, so we don't know the level of protection it found. This means we are still waiting for the crucial numbers that tell us how effective these shots were at keeping people out of the hospital during the period studied.
Bivalent COVID-19 vaccine effectiveness assessed in immunocompetent adults across nine statesDo the updated COVID-19 vaccines keep people out of the emergency room?
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Interpret preliminary bivalent vaccine effectiveness data with caution; full results are pending.
An observational study was conducted using data from the VISION Network across nine states. The population consisted of immunocompetent adults aged 18 years or older. The study aimed to evaluate the effectiveness of updated (bivalent) COVID-19 vaccines in preventing COVID-19-associated emergency department and urgent care visits and hospitalizations. A specific comparator group was not reported.
The main results for the primary outcome of preventing COVID-19-associated emergency department, urgent care, and hospital visits were not reported. No effect size, absolute numbers, p-values, or confidence intervals were provided. The direction of the effect was also not reported. No secondary outcomes were listed.
No safety or tolerability data were reported, including information on adverse events, serious adverse events, or discontinuations. The study's follow-up duration was not specified. Key limitations were not detailed in the provided information, and funding sources or potential conflicts of interest were not reported. The practice relevance of these findings cannot be determined without the complete results and methodological details from the full study.
What this means for you:
Study on updated COVID shots' real-world impact is still awaiting results. More on COVID
E3 ubiquitin ligases modulate SARS-CoV-2 replication and immune evasion through targeted protein degradation mechanisms
SARS-CoV-2 uses host enzymes to hide from the immune system
This mini-review explores the role of E3 ubiquitin ligases in the context of SARS-CoV-2 infection. The authors synthesize how these enzymes …
New research shows how the virus hijacks specific proteins in our cells to replicate and dodge our body's natural defenses.
Patients with post-COVID syndrome face significant thromboembolic risk requiring proactive monitoring and tailored anticoagulant treatments
Anticoagulant Drugs May Help Manage Thromboembolic Risks After COVID-19
This meta-analysis examines the prevalence of thromboembolic events in individuals with post-COVID syndrome. The analysis identifies a signi…
People with post-COVID syndrome may face a higher risk of blood clots, highlighting the need for proactive monitoring and tailored treatment…
Casirivimab plus imdevimab reduced risk of hospitalization or death in patients with and without asthma
Trial shows antibody treatment helps COVID-19 patients with asthma
This randomized controlled trial evaluated casirivimab plus imdevimab (CAS + IMD) in outpatients with acute COVID-19. The study found that C…
A new trial shows a dual antibody treatment reduces hospitalization and death risk for COVID-19 patients, including those with asthma or ato…
Erratum issued for COVID-19 hospitalization data among health care personnel
What happened to health care workers hospitalized with COVID-19? A correction notice.
An erratum notice was published regarding data on COVID-19-associated hospitalizations among health care personnel from the COVID-NET survei…
A correction notice clarifies that a previous report on health care workers hospitalized with COVID-19 did not contain new data or findings.
View Original Abstract ↓
This report describes the effectiveness of the updated (bivalent) COVID-19 vaccines for prevention of COVID-19 associated emergency department and urgent care visits and hospitalization among adults ages 18 years or older without a weakened immune system.
Budesonide-glycopyrronium-formoterol fumarate dihydrate improved lung function and reduced severe exacerbations versus budesonide-formoterol in inadequately controlled asthma
New Asthma Drug Cuts Attacks Without Recent Crisis
Related in Allergy & Immunology
Circular RNAs may regulate ferroptosis and anti-tumor immunity in cancer via multiple mechanisms
Circular RNAs may offer new ways to target cancer cells
This systematic review explores how circular RNAs (circRNAs) act as molecular bridges to simultaneously regulate ferroptosis and anti-tumor …
New research identifies circular RNAs as molecular bridges that could help doctors diagnose and treat cancer more precisely.
Meningeal Immune System Offers New Target for Glioblastoma Immunotherapy
New approach targets the immune system to treat brain tumors
This systematic review explores how targeting the meningeal immune system, including dural lymphatics and rBAMs, could overcome current barr…
A new strategy focuses on the area where brain tumors meet the body's defenses to improve how immunotherapy works for glioblastoma.
FDA Approves Exdensur for Add-On Maintenance Treatment of Severe Eosinophilic Asthma
FDA approves new long-acting shot Exdensur for severe asthma.
FDA approved Exdensur (IL-5 antagonist) for add-on maintenance treatment of severe eosinophilic asthma in patients aged 12 years and older. …
The FDA approved Exdensur as an add-on treatment for severe asthma in people 12 and older. It is given as a shot every six months. This new …
CD8+ T cells and associated signaling pathways influence osteoclast formation and osteoblast differentiation in osteoporosis
Immune Cells and Signaling Pathways Influence Bone Health in Osteoporosis
This narrative review synthesizes the role of CD8+ T cells and related cytokines like IFN-gamma, CCL5, and IL-33 in bone metabolism. The aut…
New research highlights how specific immune cells and signaling pathways may play a dual role in protecting or promoting bone loss in osteop…
From Other Specialties
Tocilizumab shows early anti-inflammatory effects but no significant clinical benefit in STEMI or NSTEMI
Tocilizumab shows early signs of heart protection in heart attacks
This meta-analysis of randomized controlled trials evaluated tocilizumab for patients with STEMI and NSTEMI. While the intervention showed a…
A new review looks at how the drug tocilizumab affects patients with heart attacks, showing some early signs of reduced inflammation.
Risk factors and protective behaviors identified for myopia in Chinese school students
Factors that increase or decrease myopia risk in students
This meta-analysis examined various behavioral and genetic risk factors associated with myopia among primary and secondary school students. …
New data from over 1.8 million students reveals how screen time, posture, and outdoor habits impact eye health and the development of nearsi…
Topical emollient application improves skin integrity and topical oil reduces sepsis risk in preterm neonates
Topical Oil May Reduce Sepsis Risk in Preterm Infants
This meta-analysis of 5,586 preterm neonates found that topical emollients significantly improved skin integrity (SMD -1.11). While overall …
Applying topical oils may improve skin health and reduce sepsis risk in preterm babies, according to a review of over 5,000 infants.
Once-weekly basal insulin improves HbA1c by 0.09% and time in range over daily regimens
Weekly insulin offers easier management for people with type 2 diabetes
This meta-analysis of 14 randomized controlled trials involving 8,487 subjects found that once-weekly basal insulin analogs provide superior…
A new review of clinical trials shows weekly insulin can manage blood sugar as well as daily shots while reducing the number of injections.